Nyxoah Provides Update on FDA Approvable Letter for Genio System
Expects to meet final FDA requirements for full PMA approval in the second quarter
Read more »
Nyxoah Provides Update on FDA Approvable Letter for Genio System
Expects to meet final FDA requirements for full PMA approval in the second quarter
Read more »
Nyxoah Présente une Mise à Jour Concernant la Lettre d'Approuvabilité de la FDA pour le Système Genio
Prévoit de satisfaire aux exigences finales de la FDA pour [...] Read more »
JERUSALEM, March 28, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, today reported financial results and key business [...] Read more »
IRVINE, Californie, 28 mars 2025 (GLOBE NEWSWIRE) — Read more »
IRVINE, Kalifornien, March 28, 2025 (GLOBE NEWSWIRE) — Read more »
IRVINE, Califórnia, March 27, 2025 (GLOBE NEWSWIRE) — A Read more »
IRVINE, Calif., March 27, 2025 (GLOBE NEWSWIRE) — Read more »
INFORMATIONS PRIVILÉGIÉES
INFORMATIONS RÉGLEMENTÉES
La FDA Délivre à Nyxoah une Lettre [...] Read more »
INSIDE INFORMATION
REGULATED INFORMATION
FDA Issues Nyxoah an Approvable Letter for its Genio® System
Read more »
The AI–first open work platform joins the ranks of Waymo, Nvidia, Duolingo, and more
SAN JOSE, Calif., March 18, 2025 (GLOBE NEWSWIRE) — Zoom Communications, Inc. (NASDAQ: ZM), has been named [...] Read more »